1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Rat Model Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Rat Model Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)
6 Global Rat Model Market - Breakup by Model Type
6.1 Outbred Rats
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2025-2033)
6.2 Inbred Rats
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2025-2033)
6.3 Knockout/Genetically Modified Rats
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2019-2024)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2025-2033)
6.4 Hybrid/Congenic Rats
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2019-2024)
6.4.3 Market Segmentation
6.4.4 Market Forecast (2025-2033)
6.5 Conditioned/Surgically Modified Rats
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2019-2024)
6.5.3 Market Segmentation
6.5.4 Market Forecast (2025-2033)
6.6 Immunodeficient Rats
6.6.1 Overview
6.6.2 Historical and Current Market Trends (2019-2024)
6.6.3 Market Segmentation
6.6.4 Market Forecast (2025-2033)
6.7 Attractive Investment Proposition by Model Type
7 Global Rat Model Market - Breakup by Technology
7.1 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2025-2033)
7.2 Microinjection
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2025-2033)
7.3 Embryonic Stem Cell Injection
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2019-2024)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2025-2033)
7.4 Nuclear Transfer
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2019-2024)
7.4.3 Market Segmentation
7.4.4 Market Forecast (2025-2033)
7.5 Others
7.5.1 Historical and Current Market Trends (2019-2024)
7.5.2 Market Forecast (2025-2033)
7.6 Attractive Investment Proposition by Technology
8 Global Rat Model Market - Breakup by Service
8.1 Breeding
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2025-2033)
8.2 Cryopreservation
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2025-2033)
8.3 Re-derivation
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2025-2033)
8.4 Genetic Testing
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2019-2024)
8.4.3 Market Segmentation
8.4.4 Market Forecast (2025-2033)
8.5 Quarantine
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2019-2024)
8.5.3 Market Segmentation
8.5.4 Market Forecast (2025-2033)
8.6 Others
8.6.1 Historical and Current Market Trends (2019-2024)
8.6.2 Market Forecast (2025-2033)
8.7 Attractive Investment Proposition by Service
9 Global Rat Model Market - Breakup by Therapeutic Area
9.1 Oncology
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2019-2024)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2025-2033)
9.2 Neurology
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2019-2024)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2025-2033)
9.3 Immunology
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2019-2024)
9.3.3 Market Segmentation
9.3.4 Market Forecast (2025-2033)
9.4 Toxicology
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2019-2024)
9.4.3 Market Segmentation
9.4.4 Market Forecast (2025-2033)
9.5 Others
9.5.1 Historical and Current Market Trends (2019-2024)
9.5.2 Market Forecast (2025-2033)
9.6 Attractive Investment Proposition by Therapeutic Area
10 Global Rat Model Market - Breakup by End User
10.1 Contract Research Organizations (CROs)
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2019-2024)
10.1.3 Market Segmentation
10.1.4 Market Forecast (2025-2033)
10.2 Academic and Research Institutes
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2019-2024)
10.2.3 Market Segmentation
10.2.4 Market Forecast (2025-2033)
10.3 Pharmaceutical and Biotechnology Companies
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2019-2024)
10.3.3 Market Segmentation
10.3.4 Market Forecast (2025-2033)
10.4 Attractive Investment Proposition by End User
11 Global Rat Model Market – Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Drivers
11.1.1.2 Historical and Current Market Trends (2019-2024)
11.1.1.3 Market Breakup by Model Type
11.1.1.4 Market Breakup by Technology
11.1.1.5 Market Breakup by Service
11.1.1.6 Market Breakup by Therapeutic Area
11.1.1.7 Market Breakup by End User
11.1.1.8 Key Players
11.1.1.9 Market Forecast (2025-2033)
11.1.2 Canada
11.1.2.1 Market Drivers
11.1.2.2 Historical and Current Market Trends (2019-2024)
11.1.2.3 Market Breakup by Model Type
11.1.2.4 Market Breakup by Technology
11.1.2.5 Market Breakup by Service
11.1.2.6 Market Breakup by Therapeutic Area
11.1.2.7 Market Breakup by End User
11.1.2.8 Key Players
11.1.2.9 Market Forecast (2025-2033)
11.2 Europe
11.2.1 Germany
11.2.1.1 Market Drivers
11.2.1.2 Historical and Current Market Trends (2019-2024)
11.2.1.3 Market Breakup by Model Type
11.2.1.4 Market Breakup by Technology
11.2.1.5 Market Breakup by Service
11.2.1.6 Market Breakup by Therapeutic Area
11.2.1.7 Market Breakup by End User
11.2.1.8 Key Players
11.2.1.9 Market Forecast (2025-2033)
11.2.2 France
11.2.2.1 Market Drivers
11.2.2.2 Historical and Current Market Trends (2019-2024)
11.2.2.3 Market Breakup by Model Type
11.2.2.4 Market Breakup by Technology
11.2.2.5 Market Breakup by Service
11.2.2.6 Market Breakup by Therapeutic Area
11.2.2.7 Market Breakup by End User
11.2.2.8 Key Players
11.2.2.9 Market Forecast (2025-2033)
11.2.3 United Kingdom
11.2.3.1 Market Drivers
11.2.3.2 Historical and Current Market Trends (2019-2024)
11.2.3.3 Market Breakup by Model Type
11.2.3.4 Market Breakup by Technology
11.2.3.5 Market Breakup by Service
11.2.3.6 Market Breakup by Therapeutic Area
11.2.3.7 Market Breakup by End User
11.2.3.8 Key Players
11.2.3.9 Market Forecast (2025-2033)
11.2.4 Italy
11.2.4.1 Market Drivers
11.2.4.2 Historical and Current Market Trends (2019-2024)
11.2.4.3 Market Breakup by Model Type
11.2.4.4 Market Breakup by Technology
11.2.4.5 Market Breakup by Service
11.2.4.6 Market Breakup by Therapeutic Area
11.2.4.7 Market Breakup by End User
11.2.4.8 Key Players
11.2.4.9 Market Forecast (2025-2033)
11.2.5 Spain
11.2.5.1 Market Drivers
11.2.5.2 Historical and Current Market Trends (2019-2024)
11.2.5.3 Market Breakup by Model Type
11.2.5.4 Market Breakup by Technology
11.2.5.5 Market Breakup by Service
11.2.5.6 Market Breakup by Therapeutic Area
11.2.5.7 Market Breakup by End User
11.2.5.8 Key Players
11.2.5.9 Market Forecast (2025-2033)
11.2.6 Others
11.2.6.1 Historical and Current Market Trends (2019-2024)
11.2.6.2 Market Forecast (2025-2033)
11.3 Asia Pacific
11.3.1 China
11.3.1.1 Market Drivers
11.3.1.2 Historical and Current Market Trends (2019-2024)
11.3.1.3 Market Breakup by Model Type
11.3.1.4 Market Breakup by Technology
11.3.1.5 Market Breakup by Service
11.3.1.6 Market Breakup by Therapeutic Area
11.3.1.7 Market Breakup by End User
11.3.1.8 Key Players
11.3.1.9 Market Forecast (2025-2033)
11.3.2 Japan
11.3.2.1 Market Drivers
11.3.2.2 Historical and Current Market Trends (2019-2024)
11.3.2.3 Market Breakup by Model Type
11.3.2.4 Market Breakup by Technology
11.3.2.5 Market Breakup by Service
11.3.2.6 Market Breakup by Therapeutic Area
11.3.2.7 Market Breakup by End User
11.3.2.8 Key Players
11.3.2.9 Market Forecast (2025-2033)
11.3.3 India
11.3.3.1 Market Drivers
11.3.3.2 Historical and Current Market Trends (2019-2024)
11.3.3.3 Market Breakup by Model Type
11.3.3.4 Market Breakup by Technology
11.3.3.5 Market Breakup by Service
11.3.3.6 Market Breakup by Therapeutic Area
11.3.3.7 Market Breakup by End User
11.3.3.8 Key Players
11.3.3.9 Market Forecast (2025-2033)
11.3.4 South Korea
11.3.4.1 Market Drivers
11.3.4.2 Historical and Current Market Trends (2019-2024)
11.3.4.3 Market Breakup by Model Type
11.3.4.4 Market Breakup by Technology
11.3.4.5 Market Breakup by Service
11.3.4.6 Market Breakup by Therapeutic Area
11.3.4.7 Market Breakup by End User
11.3.4.8 Key Players
11.3.4.9 Market Forecast (2025-2033)
11.3.5 Australia
11.3.5.1 Market Drivers
11.3.5.2 Historical and Current Market Trends (2019-2024)
11.3.5.3 Market Breakup by Model Type
11.3.5.4 Market Breakup by Technology
11.3.5.5 Market Breakup by Service
11.3.5.6 Market Breakup by Therapeutic Area
11.3.5.7 Market Breakup by End User
11.3.5.8 Key Players
11.3.5.9 Market Forecast (2025-2033)
11.3.6 Indonesia
11.3.6.1 Market Drivers
11.3.6.2 Historical and Current Market Trends (2019-2024)
11.3.6.3 Market Breakup by Model Type
11.3.6.4 Market Breakup by Technology
11.3.6.5 Market Breakup by Service
11.3.6.6 Market Breakup by Therapeutic Area
11.3.6.7 Market Breakup by End User
11.3.6.8 Key Players
11.3.6.9 Market Forecast (2025-2033)
11.3.7 Others
11.3.7.1 Historical and Current Market Trends (2019-2024)
11.3.7.2 Market Forecast (2025-2033)
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Drivers
11.4.1.2 Historical and Current Market Trends (2019-2024)
11.4.1.3 Market Breakup by Model Type
11.4.1.4 Market Breakup by Technology
11.4.1.5 Market Breakup by Service
11.4.1.6 Market Breakup by Therapeutic Area
11.4.1.7 Market Breakup by End User
11.4.1.8 Key Players
11.4.1.9 Market Forecast (2025-2033)
11.4.2 Mexico
11.4.2.1 Market Drivers
11.4.2.2 Historical and Current Market Trends (2019-2024)
11.4.2.3 Market Breakup by Model Type
11.4.2.4 Market Breakup by Technology
11.4.2.5 Market Breakup by Service
11.4.2.6 Market Breakup by Therapeutic Area
11.4.2.7 Market Breakup by End User
11.4.2.8 Key Players
11.4.2.9 Market Forecast (2025-2033)
11.4.3 Others
11.4.3.1 Historical and Current Market Trends (2019-2024)
11.4.3.2 Market Forecast (2025-2033)
11.5 Middle East and Africa
11.5.1.1 Market Drivers
11.5.1.2 Historical and Current Market Trends (2019-2024)
11.5.1.3 Market Breakup by Model Type
11.5.1.4 Market Breakup by Technology
11.5.1.5 Market Breakup by Service
11.5.1.6 Market Breakup by Therapeutic Area
11.5.1.7 Market Breakup by End User
11.5.1.8 Market Breakup by Country
11.5.1.9 Key Players
11.5.1.10 Market Forecast (2025-2033)
11.6 Attractive Investment Proposition by Region
12 Global Rat Model Market – Competitive Landscape
12.1 Overview
12.2 Market Structure
12.3 Market Share by Key Players
12.4 Market Player Positioning
12.5 Top Winning Strategies
12.6 Competitive Dashboard
12.7 Company Evaluation Quadrant
13 Profiles of Key Players
13.1 Biomere
13.1.1 Business Overview
13.1.2 Product Portfolio
13.1.3 Business Strategies
13.1.4 SWOT Analysis
13.1.5 Major News and Events
13.2 Charles River Laboratories International Inc.
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Business Strategies
13.2.4 Financials
13.2.5 SWOT Analysis
13.2.6 Major News and Events
13.3 Cyagen Biosciences Inc.
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Business Strategies
13.3.5 SWOT Analysis
13.3.6 Major News and Events
13.4 Envigo (Inotiv Inc.)
13.4.1 Business Overview
13.4.2 Product Portfolio
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 genOway S.A.
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Business Strategies
13.5.4 Financials
13.5.5 SWOT Analysis
13.5.6 Major News and Events
13.6 Janvier Labs
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Business Strategies
13.6.4 SWOT Analysis
13.6.5 Major News and Events
13.7 Taconic Biosciences Inc.
13.7.1 Business Overview
13.7.2 Product Portfolio
13.7.3 Business Strategies
13.7.4 SWOT Analysis
13.7.5 Major News and Events
13.8 TransViragen Inc.
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Business Strategies
13.8.4 SWOT Analysis
13.8.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
14 Global Rat Model Market - Industry Analysis
14.1 Drivers, Restraints, and Opportunities
14.1.1 Overview
14.1.2 Drivers
14.1.3 Restraints
14.1.4 Opportunities
14.1.5 Impact Analysis
14.2 Porters Five Forces Analysis
14.2.1 Overview
14.2.2 Bargaining Power of Buyers
14.2.3 Bargaining Power of Suppliers
14.2.4 Degree of Competition
14.2.5 Threat of New Entrants
14.2.6 Threat of Substitutes
14.3 Value Chain Analysis
15 Strategic Recommendations
16 Appendix